fluoxetine has been researched along with Cerebral Infarction in 12 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty four patients suffered from the depression after acute cerebral infarction were randomly divided into three groups: depression control group, fluoxetine treated group and Jieyu Huoxue Decoction treated group." | 5.11 | [Influence of Jieyu Huoxue Decoction on rehabilitation of patients with depression after cerebral infarction]. ( Feng, BL; Li, ZY; Wang, QC, 2004) |
| "Fluoxetine was injected intraperitoneally in a dose of 20 mg/kg for 10 days after surgery." | 1.48 | Effects of Fluoxetine on Hippocampal Neurogenesis and Neuroprotection in the Model of Global Cerebral Ischemia in Rats. ( Chernysheva, G; Khodanovich, M; Kisel, A; Krutenkova, E; Kudabaeva, M; Plotnikov, M; Smolyakova, V; Wasserlauf, I; Yarnykh, V, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khodanovich, M | 1 |
| Kisel, A | 1 |
| Kudabaeva, M | 1 |
| Chernysheva, G | 1 |
| Smolyakova, V | 1 |
| Krutenkova, E | 1 |
| Wasserlauf, I | 1 |
| Plotnikov, M | 1 |
| Yarnykh, V | 1 |
| Xiao, W | 1 |
| Zhang, XB | 1 |
| Hu, HX | 1 |
| Wang, Z | 1 |
| Guo, XL | 1 |
| Brunkhorst, R | 1 |
| Friedlaender, F | 1 |
| Ferreirós, N | 1 |
| Schwalm, S | 1 |
| Koch, A | 1 |
| Grammatikos, G | 1 |
| Toennes, S | 1 |
| Foerch, C | 1 |
| Pfeilschifter, J | 1 |
| Pfeilschifter, W | 1 |
| He, W | 1 |
| Cai, D | 1 |
| Lin, L | 1 |
| Fang, Y | 1 |
| Zheng, X | 1 |
| Feng, BL | 1 |
| Wang, QC | 1 |
| Li, ZY | 1 |
| Zhao, CS | 1 |
| Puurunen, K | 1 |
| Schallert, T | 1 |
| Sivenius, J | 1 |
| Jolkkonen, J | 1 |
| Lauterbach, EC | 2 |
| Price, ST | 1 |
| Spears, TE | 1 |
| Jackson, JG | 1 |
| Kirsh, AD | 1 |
| Stamenkovic, M | 1 |
| Schindler, S | 1 |
| Kasper, S | 1 |
| Arya, DK | 1 |
| Low, BL | 1 |
| Chong, SA | 1 |
| Brown, KW | 1 |
| Sloan, RL | 1 |
| Pentland, B | 1 |
4 trials available for fluoxetine and Cerebral Infarction
| Article | Year |
|---|---|
[Acupuncture and drug for subcortical ischemic vascular disease complicated with depression: a randomized controlled trial].
Topics: Acupuncture Points; Acupuncture Therapy; Adult; Aged; Cerebral Infarction; Depression; Female; Fluox | 2014 |
Clinical studies on event-related potentials (ERPs) N400 and the related factors in patients with poststroke depression (PSD).
Topics: Aged; Antidepressive Agents, Second-Generation; Blood Platelets; Cerebral Hemorrhage; Cerebral Infar | 2010 |
[Influence of Jieyu Huoxue Decoction on rehabilitation of patients with depression after cerebral infarction].
Topics: Aged; Antidepressive Agents, Second-Generation; Cerebral Infarction; Depression; Drugs, Chinese Herb | 2004 |
Fluoxetine as a treatment for post-stroke emotionalism.
Topics: Aged; Antidepressive Agents; Cerebral Infarction; Double-Blind Method; Female; Fluoxetine; Humans; M | 1998 |
8 other studies available for fluoxetine and Cerebral Infarction
| Article | Year |
|---|---|
Effects of Fluoxetine on Hippocampal Neurogenesis and Neuroprotection in the Model of Global Cerebral Ischemia in Rats.
Topics: Animals; Cerebral Infarction; Fluoxetine; Hippocampus; Male; Neurogenesis; Neuroprotective Agents; R | 2018 |
Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine.
Topics: Animals; Ceramides; Cerebral Cortex; Cerebral Infarction; Enzyme Inhibitors; Fluoxetine; Intracrania | 2015 |
Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury.
Topics: Affect; Aggression; Aging; Animals; Antidepressive Agents; Antipsychotic Agents; Behavior, Animal; B | 2005 |
Serotonin responsive and nonresponsive diurnal depressive mood disorders and pathological affect in thalamic infarct associated with myoclonus and blepharospasm.
Topics: Blepharospasm; Cerebral Infarction; Circadian Rhythm; Depressive Disorder; Female; Fluoxetine; Human | 1994 |
Fluoxetine withdrawal and thalamic pain.
Topics: Cerebral Infarction; Depression; Female; Fluoxetine; Humans; Middle Aged; Pain; Thalamus; Time Facto | 1994 |
[Therapy of post-stroke depression with fluoxetine. A pilot project].
Topics: Aged; Antidepressive Agents, Second-Generation; Cerebral Infarction; Depressive Disorder; Female; Fl | 1996 |
Existing brain condition may predispose to SSRI-induced extrapyramidal symptoms.
Topics: Akathisia, Drug-Induced; Basal Ganglia Diseases; Bipolar Disorder; Cerebral Infarction; Female; Fluo | 1997 |
Treating poststroke pathologic crying with fluoxetine.
Topics: Cerebral Infarction; Crying; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake I | 1998 |